L

lecanumab

Product

by Eisai and Biogen

Heard in 4 episodes across 4 shows since Aug 2026

Lecanemab is an anti-amyloid monoclonal antibody approved for eligible people with early Alzheimer's disease to reduce brain amyloid and modestly slow clinical decline.

Episodes

4
across 4 shows

First heard

Aug 2026

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20260
Aug 20261
Sep 20262
Oct 20261
Nov 20260

Email alert

Email me when lecanumab comes up on a podcast

One email a week at most, with the new episodes that mention lecanumab. Free, no account needed, unsubscribe in one click.

Episodes

4 episodes featuring lecanumab, newest first